Literature DB >> 19286648

Adult-onset degeneration of adipose tissue in mice deficient for the Sox8 transcription factor.

Sabine I E Guth1, Katy Schmidt, Andreas Hess, Michael Wegner.   

Abstract

Although the transcription factor Sox8 is broadly expressed during embryogenesis in developing ectodermal and mesodermal tissues, mice develop surprisingly normally in the absence of Sox8. Phenotypes in adult Sox8-deficient mice include mild osteopenia, late-onset male infertility, and reduced weight. We show here that progressive degeneration of adipose tissue in adult Sox8-deficient mice significantly contributes to weight reduction. Although serum levels of leptin, IGF-1, and noradrenaline were altered in Sox8-deficient mice, these changes could not explain the observed phenotype. Other serum parameters, including indicators of glucose metabolism, were largely normal. However, expression of the preadipocyte marker Pref-1 was elevated in adipose tissues of Sox8-deficient mice. This increase correlated with an impaired differentiation of Sox8-deficient fibroblasts to adipocytes in culture, a defect that could be rescued by reintroducing Sox8 into the cells. Furthermore, Sox8 levels were higher in mesodermal precursors than in mature adipocytes. We postulate a precursor-intrinsic role of Sox8 during replenishment of the adipocyte pool in adult mice and assume that disturbance of this function significantly contributes to adipose tissue degeneration in Sox8-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286648      PMCID: PMC2694327          DOI: 10.1194/jlr.M800531-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

1.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10.

Authors:  C Claus Stolt; Stephan Rehberg; Marius Ader; Petra Lommes; Dieter Riethmacher; Melitta Schachner; Udo Bartsch; Michael Wegner
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

2.  Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; Richard R Behringer; David H Rowitch; Andreas Schedl; Jonathan A Epstein; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

3.  Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus.

Authors:  C C Cheung; D K Clifton; R A Steiner
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

4.  Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene.

Authors:  T Tanaka; N Yoshida; T Kishimoto; S Akira
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

5.  Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the beta 3-adrenoceptor agonists BRL 35135A and ZD2079.

Authors:  P Trayhurn; J S Duncan; D V Rayner; L J Hardie
Journal:  Biochem Biophys Res Commun       Date:  1996-11-12       Impact factor: 3.575

6.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

7.  Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model.

Authors:  E M Southard-Smith; L Kos; W J Pavan
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

8.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene.

Authors:  J W Foster; M A Dominguez-Steglich; S Guioli; C Kwok; P A Weller; M Stevanović; J Weissenbach; S Mansour; I D Young; P N Goodfellow
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

9.  Impaired energy homeostasis in C/EBP alpha knockout mice.

Authors:  N D Wang; M J Finegold; A Bradley; C N Ou; S V Abdelsayed; M D Wilde; L R Taylor; D R Wilson; G J Darlington
Journal:  Science       Date:  1995-08-25       Impact factor: 47.728

10.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9.

Authors:  T Wagner; J Wirth; J Meyer; B Zabel; M Held; J Zimmer; J Pasantes; F D Bricarelli; J Keutel; E Hustert; U Wolf; N Tommerup; W Schempp; G Scherer
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

View more
  4 in total

1.  In mammalian skeletal muscle, phosphorylation of TOMM22 by protein kinase CSNK2/CK2 controls mitophagy.

Authors:  Bojana Kravic; Angelika B Harbauer; Vanina Romanello; Luca Simeone; F-Nora Vögtle; Tobias Kaiser; Marion Straubinger; Danyil Huraskin; Martin Böttcher; Cristina Cerqua; Eva Denise Martin; Daniel Poveda-Huertes; Andreas Buttgereit; Adam J Rabalski; Dieter Heuss; Rüdiger Rudolf; Oliver Friedrich; David Litchfield; Michael Marber; Leonardo Salviati; Dimitrios Mougiakakos; Winfried Neuhuber; Marco Sandri; Chris Meisinger; Said Hashemolhosseini
Journal:  Autophagy       Date:  2018-02-01       Impact factor: 16.016

2.  SOX9 controls epithelial branching by activating RET effector genes during kidney development.

Authors:  Antoine Reginensi; Michael Clarkson; Yasmine Neirijnck; Benson Lu; Takahiro Ohyama; Andrew K Groves; Elisabeth Sock; Michael Wegner; Frank Costantini; Marie-Christine Chaboissier; Andreas Schedl
Journal:  Hum Mol Genet       Date:  2011-01-06       Impact factor: 6.150

3.  Sox21 deletion in mice causes postnatal growth deficiency without physiological disruption of hypothalamic-pituitary endocrine axes.

Authors:  Leonard Y M Cheung; Hideyuki Okano; Sally A Camper
Journal:  Mol Cell Endocrinol       Date:  2016-09-08       Impact factor: 4.102

4.  Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases.

Authors:  Priyanka Nakka; Benjamin J Raphael; Sohini Ramachandran
Journal:  Genetics       Date:  2016-08-03       Impact factor: 4.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.